From: Abnormal glucose regulation in Chinese patients with coronary artery disease: a gender analysis
 | Male (n = 1340) | Female (n = 572) | ||||||
---|---|---|---|---|---|---|---|---|
DM (n = 636) | NDM (n = 83) | IGR (n = 283) | Normal (n = 338) | DM (n = 317) | NDM (n = 41) | IGR (n = 105) | Normal (n = 109) | |
Lipid profile | Â | Â | Â | Â | Â | Â | Â | Â |
 TC | 3.81 (3.28,4.55) | 3.92 (3.50,5.08) | 4.07 (3.41,4.71) | 3.99 (3.38,4.61) | 4.05 (3.47,4.76) | 4.31 (3.67,5.02) | 4.17 (3.58,4.83) | 4.46 (3.70,4.96) |
 HDL-C | 1.04 (0.88,1.24) | 1.02 (0.90,1.24) | 1.10 (0.94,1.28) | 1.12 (0.97,1.30) | 1.16 (0.95,1.39) | 1.27 (1.08,1.54) | 1.23 (1.07,1.45) | 1.34 (1.14,1.54) |
 LDL-C | 1.96 (1.54,2.51) | 2.22 (1.77,3.05) | 2.20 (1.64,2.66) | 2.13 (1.62,2.63) | 2.11 (1.61,2.75) | 2.41 (1.61,2.82) | 2.03 (1.60,2.52) | 2.31 (1.71,2.71) |
 TG | 1.52 (1.10,2.20) | 1.48 (1.12,2.31) | 1.39 (1.04,2.04) | 1.35 (0.98,1.93) | 1.44 (1.06,2.02) | 1.48 (1.15,2.04) | 1.54 (1.10,2.01) | 1.39 (1.01,1.84) |
Blood glucose | Â | Â | Â | Â | Â | Â | Â | Â |
 RBG | 10.4 (7.6,12.7) | 9.7 (8.1,13.1) | 6.8 (5.4,7.6) | 6.3 (5.3,7.3) | 13.2 (9.6,15.6) | 10.1 (8.0,11.5) | 7.4 (6.2,10.2) | 6.7 (6.4,7.3) |
 FBG | 6.7 (5.3,7.9) | 5.7 (4.9,6.5) | 4.9 (4.4,5.4) | 4.7 (4.0,5.0) | 7 (6.1,9.6) | 5.6 (5.6,6.6) | 4.9 (4.8,5.0) | 4.8 (4.5,5.1) |
 OGTT- 0Hr | 5.7 (4.8,6.6) | 5.1 (4.8,5.6) | 4.4 (4.0,5.2) | 4.4 (4.1,4.8) | 6.4 (5.1,9.1) | 5.4 (4.9,5.9) | 4.6 (4.4,4.9) | 4.4 (4.1,4.5) |
 OGTT—2Hr | 14.2 (12.0,15.3) | 13.2 (12.5,15.0) | 9.1 (8.5,9.7) | 6.0 (5.3,7.0) | 13.6 (12.1,15.8) | 12.3 (11.6,13.6) | 8.3 (7.8,8.6) | 6.1 (5.6,6.7) |
 HbA1C | 6.6 (6.2,7.6) | 6 (5.9,6.4) | 5.7 (5.3,6.4) | 5.6 (5.4,5.8) | 7.2 (6.6,8.5) | 6.1 (6.1,6.2) | 6.1 (5.9,6.2) | 5.6 (5.3,5.9) |